Acquisition of Medicines for the Second Quarter of the Municipality of Sabaya (Declared Void)

BoliviaTenders notice for Acquisition of Medicines for the Second Quarter of the Municipality of Sabaya (Declared Void). The reference ID of the tender is 110795865 and it is closing on 28 Nov 2024.

100% Secure Payments

Tender Details

  • Country: Bolivia
  • Summary: Acquisition of Medicines for the Second Quarter of the Municipality of Sabaya (Declared Void)
  • BOT Ref No: 110795865
  • Deadline: 28 Nov 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: 24-1431-00-1500217-1-1
  • Purchaser's Detail :
  • Purchaser : AUTONOMOUS MUNICIPAL GOVERNMENT OF SABAYA
    Roxana Barco Condori (Phone 25134116)

  • Description :
  • Bidders are invited to Acquisition of medicines for the second quarter of the municipality of Sabaya (declared void)
    Status: Current
    Entity: Municipal Autonomous Government of Sabaya
    Department: Oruro
    Publication date: November 25, 2024
    Modality: Minor Contracting - C.M.
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BoliviaTenders Features

BoliviaTenders Features

Fresh and verified Tenders from Bolivia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bolivia in your email inbox.

  Chat with us